Last updated on April 2019

A Study to Evaluate Efficacy in Subjects With Esophageal Cancer Treated With Nivolumab and Ipilimumab or Nivolumab Combined With Fluorouracil Plus Cisplatin Versus Fluorouracil Plus Cisplatin

Brief description of study

The main purpose of this study is to compare how long subjects with esophageal cancer live overall or live without disease progression after receiving nivolumab and ipilimumab or nivolumab combined with fluorouracil plus cisplatin versus fluorouracil plus cisplatin

Clinical Study Identifier: NCT03143153

Contact Investigators or Research Sites near you

Start Over

Local Institution

Bunkyo-ku, Japan
  Connect »

Local Institution

Sagamihara-shi, Japan
  Connect »

Local Institution

Kawasaki-shi, Japan
  Connect »

Local Institution

Yokohama-shi, Japan
  Connect »

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.